Displaying 1 to 20 of 64 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development |
United States | N/A Active |
||
|
|
Afferent Pharmaceuticals Inc |
United States | N/A Active |
||
|
|
Anthera Pharmaceuticals Inc |
United States | N/A Active |
||
|
Arena Pharmaceuticals Inc |
United States | N/A |
||
|
|
ArgoMed |
United States | N/A |
||
|
|
Athersys Inc Develops therapeutic products to treat significant and life-threatening diseases. |
United States | N/A Active |
||
|
|
BaroSense Inc A medical device company |
United States | N/A |
||
|
|
Bayhill Therapeutics A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. |
United States | N/A |
||
|
|
BioSyntech A medical device company |
Canada | N/A |
||
|
|
Bloodhound Technologies Medical claims processing software company. |
United States | N/A |
||
|
|
BrainCells Inc A neurogenesis-based drug discovery and development company targeting novel therapies for mood disorders and other central nervous system diseases. |
United States | N/A |
||
|
|
Calyx Therapeutics |
United States | N/A |
||
|
CardioDx Inc |
United States | 17 May 2010 | Series D Initial investment. Round participant. Active |
|
|
|
CardioDx Inc |
United States | 11 May 2011 | Series E Initial investment. Round participant. Active |
|
|
|
CardioDx Inc |
United States | 1 Aug 2012 | Series F Initial investment. Round participant. Active |
|
|
|
CeNeRx BioPharma Inc A specialty biopharmaceutical company |
United States | N/A |
||
|
|
Cequent Pharmaceuticals |
United States | N/A |
||
|
|
Cerexa Inc |
United States | N/A |
||
|
|
Chimerix Inc |
United States | 1 Feb 2011 | Series F |